Faiz Ullah Khan | Pharmacology Toxicology and Pharmaceutical Science | Editorial Board Member

Published on by Young Scientists Awards

Dr. Faiz Ullah Khan | Pharmacology Toxicology and Pharmaceutical Science
| Editorial Board Member

Peking University | China

Dr. Faiz Ullah Khan is a pharmacy researcher and academic specializing in clinical pharmacy, pharmacy administration, antimicrobial stewardship, and public health pharmacy. He is currently engaged in postdoctoral research focusing on antibiotic use, resistance, and optimized therapeutic interventions. His academic journey includes a PhD in Pharmacy Administration and Clinical Pharmacy, with prior training in pharmacy practice and clinical pharmacology across leading institutions in Asia and Europe.Dr. Khan has previously served in various academic and research roles, including Assistant Professor and Head of a Clinical Pharmacy Section, senior lecturer positions, and research fellowships. His doctoral work emphasized antibiotic adherence, stewardship programs, and mixed-methods research design, contributing significantly to the understanding of antibiotic misuse and public health challenges in low- and middle-income settings. He has authored numerous peer-reviewed publications across reputable international journals, covering topics such as antimicrobial resistance, clinical interventions, pharmacovigilance, vaccine acceptance, and quality-of-life assessments. In addition, he has contributed multiple book chapters focusing on medication safety, public health education, and pharmacist-led care. Dr. Khan is frequently invited as a guest speaker at international conferences and forums and actively contributes as a reviewer and guest editor for various scientific journals. His professional interests also extend to mentoring postgraduate and undergraduate students, leading academic initiatives, and promoting safe and rational medicine use through research, teaching, and community engagement.

Featured Publications

Muhammad, K., Saqlain, M., Muhammad, G., Hamdard, A., Naveed, M., Butt, M. H., … Khan, F. U. (2022)
Knowledge, attitude, and practices (KAPs) of community pharmacists regarding COVID-19: A cross-sectional survey in two provinces of Pakistan. Disaster Medicine and Public Health Preparedness, 16(5), 1864–1872.
https://doi.org/10.1017/dmp.2021.17 (If a DOI exists—this is the correct DOI for the article.)

Khan, F. U., Khan, F. U., Hayat, K., Chang, J., Saeed, A., Khan, Z., Ashraf, M., … Fang, Y. (2020)
Knowledge, attitude, and practices among consumers toward antibiotic use and antibiotic resistance in Swat, Khyber-Pakhtunkhwa, Pakistan. Expert Review of Anti-Infective Therapy, 18(9), 937–946.
https://doi.org/10.1080/14787210.2020.1769477

 Khan, F. U., Khan, F. U., Hayat, K., Ahmad, T., Khan, A., Chang, J., Malik, U. R., … Fang, Y. (2021).
Knowledge, attitude, and practice on antibiotics and its resistance: A two-phase mixed-methods online study among Pakistani community pharmacists to promote rational antibiotic use. International Journal of Environmental Research and Public Health, 18(3), 1320.
https://doi.org/10.3390/ijerph18031320

Shivang Shukla | Pharmacy | Young Researcher Award

Published on by Young Scientists Awards

Mr. Shivang Shukla l Pharmacy
| Young Researcher Award

Jagannath University | India

The research focuses on advancing pharmacological science through multidisciplinary approaches involving drug discovery, nanotechnology, computational modeling, and translational pharmacology. Current investigations explore the computational identification of skeletal muscle-specific AMPK activators for type-2 diabetes therapy, aiming to enhance metabolic regulation and therapeutic efficacy. Additional studies examine the cardioprotective potential of Artocarpus heterophyllus against isoprenaline-induced myocardial infarction and the neuroprotective role of Coenzyme Q10 as an adjuvant to nanostructured lipid carriers loaded with Adenium obesum in ethanol-induced cognitive impairment models. The work integrates molecular biology, biochemistry, and pharmacokinetic analysis to identify novel therapeutic pathways and biomarker targets. Emphasis is also placed on nanocarrier-based drug delivery for neurological and cardiovascular disorders, focusing on improving bioavailability and site-specific targeting. Parallel research on nanotherapeutics addresses challenges in treating conditions such as Alzheimer’s disease, psoriasis, and Clostridioides difficile infection. The studies utilize a combination of in silico, in vitro, and in vivo methodologies to develop innovative solutions in pharmacology and toxicology. Through experimental validation and advanced modeling, this research contributes to understanding drug mechanisms, enhancing safety profiles, and formulating next-generation therapeutics for complex diseases, thereby supporting the global goal of precision medicine and sustainable healthcare innovation.

Featured Publications

Rai, A., Shukla, S., Gupta, R. K., & Mishra, A. (2025). ALS: A silent slayer of motor neurons. Traditional Chinese herbal medicine as an effective therapy. Current Pharmaceutical Design.

Singh, V., Ravindranath, S. K., Verma, H., Shukla, S., Rai, A., Patani, T., Mishra, T., Mishra, A., & Gupta, R. K. (2025). Harnessing traditional Chinese medicine for wound healing and modern wound models: An overview. Pharmacological Research: Modern Chinese Medicine.

Pal, R., Shukla, S., Rai, A., & Sharma, A. (2025, September 25). Nano-brain revolution in Alzheimer’s disease: A new era of brain drug delivery. [Book].

Pal, R., Shukla, S., Gupta, R. K., Rai, A., & Sharma, P. (2025, September 13). From ancient roots to nano routes: Targeted delivery of Ginkgo and Gastrodia for Parkinson’s disease (PD) treatment. [Book].

Pooja Kumari | Pharmaceutical Chemistry | Women Researcher Award

Published on by Young Scientists Awards

Ms. Pooja Kumari | Pharmaceutical Chemistry
| Women Researcher Award

JSS college of pharmacy, mysore | India

Ms. Pooja Kumari is an accomplished pharmaceutical researcher with over four years of experience in drug design, synthetic and medicinal chemistry, and scientific writing. She has expertise in computational approaches, including molecular docking, molecular dynamics simulation, QSAR, and homology modeling, alongside hands-on laboratory synthesis of novel compounds. Her Ph.D. research at JSS University focuses on designing and synthesizing novel purine derivatives as Aurora kinase-A inhibitors for breast cancer, integrating in-silico modeling with biochemical evaluation. She has contributed to medicinal chemistry through publications on pyrimidine, pyrazole, benzimidazole, and benzoxazole scaffolds, as well as reviews on pharmacogenomics and oncogenic signaling pathways, with 3 documents, 7 citations, and an h-index of 1. Pooja also has four years of teaching experience and practical guidance experience as a Research Assistant at SriramChem Laboratories. A registered pharmacist in India, she has completed workshops and certifications in AI-driven drug discovery and journal reviewing. Fluent in English and Hindi, she is currently enhancing her Dutch proficiency, reflecting adaptability and commitment to cross-cultural engagement. Her multidisciplinary expertise and strong analytical and communication skills enable her to contribute effectively in academic, research, and regulated pharmaceutical environments.

Profile: Orcid | Scopus 

Featured Publication

Kumari, P. (2026). Exploring pyrimidine scaffolds for cancer therapy: A triad of synthetic chemistry, computational studies, and in-vitro biological testing. Journal of Molecular Structure.

 

 

Vanktesh Kumar | Pharma | Young Researcher Award

Published on by Young Scientists Awards

Mr. Vanktesh Kumar | Pharma | Young Researcher Award

Lovely professional university, India

Vanktesh Kumar, in Ludhiana, Punjab, is a passionate and skilled medicinal chemist with expertise in analytical, synthetic, and pharmaceutical chemistry. Currently pursuing his Ph.D. in Pharmaceutical Chemistry from Lovely Professional University, he has held pivotal research roles at MacLeods Pharmaceuticals Ltd. and the Regional Center for Biotechnology. His research bridges cancer biology, nanotechnology, and drug discovery, focusing on kinase inhibitors and herbal neurotherapeutics. With multiple impactful publications and technical skills, Vanktesh continues to make significant contributions to drug design, synthesis, and pharmaceutical innovation.

Profile

🎓 Education

Vanktesh Kumar is currently pursuing his Ph.D. in Pharmaceutical Chemistry (2024) from Lovely Professional University, following an M.Pharm in the same discipline (2021) with a CGPA of 8.60. He earned his B.Pharm from Govt. Institute of Pharmaceutical Sciences (2019) with 8.52 CGPA. Prior to that, he studied Intermediate-Science (PCB) at SCD Govt. College (2015), securing 89.56%, and completed his matriculation from Mukt Vidya Mandir School in 2013 with 79.56%. His strong academic background in pharmaceutical sciences and analytical chemistry underpins his robust research capabilities and technical excellence in the field.

💼 Experience

Vanktesh has served as an Executive Research Analyst at MacLeods Pharmaceuticals Ltd. (2021–2023), where he conducted rigorous analytical evaluations of drug compounds using HPLC, UV-Vis, AAS, and more, contributing to drug development and quality control. Since 2023, he’s been working at RCB, Faridabad, in collaboration with NII and AIIMS New Delhi, on cancer biology projects involving lipidomics, nanotech, and patient-derived cancer cells. His work also includes biomarker identification and post-surgical outcome tracking, showcasing his deep involvement in translational research with clinical relevance.

🏅 Awards & Honors

Vanktesh Kumar has been recognized for his outstanding contributions to pharmaceutical research through multiple peer-reviewed publications in reputed journals and book chapters. His scholarly work includes comprehensive reviews, docking studies, and experimental designs that reflect high-level academic and practical insight. Contributing chapters to international scientific volumes by publishers like Walter de Gruyter and Academic Press, and publishing in journals such as Current Medicinal Chemistry and Chemical Biology & Drug Design, affirms his status as an emerging researcher. His ongoing doctoral work and research collaborations with prestigious institutions highlight his dedication and growing recognition.

🔬 Research Focus

Vanktesh focuses on medicinal and pharmaceutical chemistry, specifically drug design, synthesis, and evaluation of kinase inhibitors for cancer therapy. His doctoral project targets AXL kinase with novel 2-(1,3-dioxoisoindolin-2-yl)-N-substituted phenyl-acetamide derivatives using in silico modeling, synthesis, and in vitro evaluation. He’s also investigated herbal neuroprotective agents, isolating bioactives using LC-MS, HPLC, and NMR. His work spans nanomedical drug delivery, phytopharmacology, and computational chemistry. Combining analytical methods with synthetic innovation, his goal is to discover and develop next-generation therapeutics addressing oncology, neurology, and metabolic disorders.

 Conclusion

Mr. Vanktesh Kumar demonstrates outstanding potential as a young medicinal chemist, blending analytical expertise, computational modeling, and applied research in oncology and neuropharmacology. His publications, technical proficiencies, and current Ph.D. work on targeted cancer therapy represent significant scientific merit. With added focus on global collaboration, leadership roles, and translational outputs like patents or clinical leads, he would be a strong and deserving candidate for the Young Scientist Award.

Publication

Title: Alpha‐amylase as molecular target for treatment of diabetes mellitus: A comprehensive review
Year: 2021
Authors: N Kaur, V Kumar, SK Nayak, P Wadhwa, P Kaur, SK Sahu
Cited by: 275

Title: Clinical evidence on the effects of saffron (Crocus sativus L.) in anxiety and depression
Year: 2022
Authors: V Kumar, N Kaur, P Wadhwa
Cited by: 13

Title: Role of tyrosine kinases and their inhibitors in cancer therapy: a comprehensive review
Year: 2023
Authors: V Kumar, N Kaur, S Sahu, V Sharma, D Kumar, A Sharma, P Wadhwa
Cited by: 11

Title: Nanomedical drug delivery for neurodegenerative disease
Year: 2022
Authors: N Kaur, V Kumar, T Mahender, I Maji, S Mahajan, M Aalhate, PK Singh, …
Cited by: 11

Title: Phytochemistry and Pharmacology of Indian Traditional Plant Hyssop (Hyssopus officinalis L.): A Review
Year: 2023
Authors: V Kumar, N Kaur, A Kaur, P Wadhwa
Cited by: 7

Title: Homoisoflavonoids: isolation, chemical synthesis strategies and biological activities
Year: 2020
Authors: V Kumar, SK Nayak
Cited by: 4

Title: A review over the effect of heavy metal in metabolism of Brassica juncea (L.) and Myristica fragrans
Year: 2021
Authors: V Kumar, N Kaur, P Wadhwa
Cited by: 3

Title: Role of structural genomics in drug discovery
Year: 2024
Authors: A Mehra, V Kumar, B Kapoor, M Gulati, P Wadhwa

Title: Computational Drug Discovery: Molecular Simulation for Medicinal Chemistry
Year: 2024
Authors: MGP Anuradha Mehra, Vanktesh Kumar, Bhupinder Kapoor

Title: A Review on Inhibitory Action of Tyrosine Kinase Inhibitors (TKI) by Curbing the ATP-Tyrosine Kinase Interactions
Year: 2023
Authors: V Kumar, N Kaur

Title: CULTIVATION AND COLLECTION OF SOME PLANTS WITH THEIR SIGNIFICANCE ROLE IN DIABETES MELLITUS: A COMPREHENSIVE REVIEW
Year: 2021
Authors: N KAUR, V KUMAR, P WADHWA

Title: A Review on Role of Cyclin-Dependent Kinase (CDK) Enzyme and their Inhibitor
Year: 2020
Authors: S Dey, V Kumar, P WadhwaTitle: The Important Nutritional and Wonderful Health Benefits of Cashew (Anacardium occidentale L.)
Year: Not listed
Authors: V Kumar, N Kaur, A Kaur, P Wadhwa

Ali Yousefi | medicinal chemistry | Best Researcher Award

Published on by Young Scientists Awards

Mr. Ali Yousefi | Medicinal Chemistry | Best Researcher Award

Ali Yousefi, an Iranian medicinal chemist born in 1998, is a Ph.D. scholar at Tabriz University of Medical Sciences and an emerging researcher at the University of Kashan’s Essential Oils Research Institute. With a strong foundation in pure and medicinal chemistry, his research explores the synthesis and biological evaluation of bioactive compounds, integrating AI and natural product chemistry. He has contributed to cutting-edge publications, presented at national conferences, and taken part in interdisciplinary collaborations. Ali is deeply invested in drug discovery, natural product isolation, and cancer-related research, aiming to bridge traditional remedies with modern medicinal approaches.

Profile

Scopus

🎓 Education 

Ali Yousefi earned a B.Sc. in Pure Chemistry (2017–2023) and an M.Sc. in Medicinal Chemistry (2021–2023) from the University of Kashan, Iran, through its Distinguished Talent Program. Currently, he is pursuing a Ph.D. in Medicinal Chemistry (2023–2027) at the Faculty of Pharmacy, Tabriz University of Medical Sciences. His educational focus spans organic synthesis, drug design, and biological screening of novel compounds. His academic trajectory reflects both rigorous training and an innovative outlook, particularly in linking medicinal chemistry with computational modeling and natural compound exploration for therapeutic applications.

💼 Experience 

Ali has served as a teaching assistant and lecturer in undergraduate and graduate courses, including Organic Chemistry, Medicinal Chemistry, and Analytical Chemistry. He is actively involved in industrial R&D at the Shahid Ardeshir Hosseinpour Incubation Center, contributing to the synthesis and localization of Sugammadex production. A key member of the Essential Oils Research Institute since 2007, he has also contributed to AI-healthcare integrations such as Pharm Chatbot AI. At Tabriz University, he supports research in marine-derived anticancer agents, merging pharmaceutical innovation with machine learning in biological predictions.

🏅 Awards and Honors 

Ali was selected for the Distinguished Talent Program at the University of Kashan for his M.Sc. studies in Medicinal Chemistry. He has earned national recognition through his publications in high-impact journals and presentations at prestigious chemistry and medical symposia. His work in AI-integrated drug development and radiation side-effect prediction has positioned him as a promising young scientist. His role in cross-institutional industrial collaborations also demonstrates his leadership in translational research and his early career distinction in medicinal chemistry and bioinformatics.

🔬 Research Focus 

Ali’s research centers on drug discovery through the design, synthesis, and evaluation of biologically active compounds such as resveratrol and bromophenol derivatives. He is deeply interested in antioxidant, anticancer, and antimicrobial agents from natural and marine sources. His work spans computational drug design, structure-activity relationship studies, and AI applications in predicting biological responses. He also explores electrochemical biosensing and nanomaterial interfaces for biomedical diagnostics. Overall, Ali’s interdisciplinary approach bridges chemistry, pharmacology, and data science for impactful advancements in precision medicine.

📝 Conclusion

Ali Yousefi is an excellent candidate for the Best Researcher Award, demonstrating a compelling blend of academic brilliance, innovative thinking, practical application, and multidisciplinary research expertise. His active contributions in medicinal chemistry, machine learning for healthcare, natural products, and industrial pharma solutions highlight both depth and breadth of scientific engagement. With enhanced international collaboration and greater focus on innovation outputs (patents, grants), he is poised to become a rising star in pharmaceutical and biomedical research. Given his early career accomplishments and forward-thinking approach, he is strongly recommended for recognition through this prestigious award.

Publication

  • Title: Design, Synthesis and Antioxidant, Anticancer and Antimicrobial Activity Evaluation of Novel Resveratrol Derivatives

  • Year: 2025

  • Authors: Ali A. Yousefi, Abdolrasoul H. Ebrahimabadi, Hourieh Sadat Oboudatian

Syed Luqman Ali | Drug Design | Best Researcher Award

Published on by Young Scientists Awards

Mr. Syed Luqman Ali | Drug Design | Best Researcher Award

Researcher, Abdul Wali Khan University Mardan KPK Pakistan, Pakistan

Mr. Syed Luqman Ali is an enthusiastic researcher specializing in bioinformatics, computational biology, vaccine design, cancer, and drug development. Currently pursuing an MPhil in Biochemistry at Abdul Wali Khan University Mardan (2025), he has published extensively on vaccine and drug design using advanced computational techniques like RNA-seq, molecular docking, and simulation. Mr. Ali is a skilled reviewer for several high-impact journals and a lecturer at Metanoia College of Nursing. With expertise in bioinformatics tools and programming languages, he is committed to advancing scientific knowledge in vaccine and drug research.

Publication Profile

Google scholar

Education

Mr. Syed Luqman Ali is currently pursuing his MPhil in Biochemistry at Abdul Wali Khan University Mardan, Pakistan, with an expected graduation in 2025. He completed his Bachelor’s degree in Biochemistry from the same institution in 2022, laying the foundation for his research career. Additionally, he holds a Diploma in Digital Information Technology from the Board of Technical Education Peshawar, Pakistan, earned in 2021. This diverse educational background has equipped him with a strong interdisciplinary skill set, combining biochemistry, digital technology, and computational biology for cutting-edge research.

Research Experience

Mr. Syed Luqman Ali has been an Experimental and Computational Researcher at Abdul Wali Khan University Mardan since 2019. His research focuses on vaccine and drug design, utilizing advanced computational techniques like RNA-seq analysis, molecular docking, and simulation. With extensive experience in leading bioinformatics databases such as KEGG, MetaCyc, and HADDOCK, Mr. Ali is proficient in tools like SnapGene, Cytoscape, and DAVID. His work contributes to the development of innovative vaccines and drug therapies, advancing scientific knowledge in bioinformatics and computational biology.

Technical Certifications

Mr. Syed Luqman Ali has acquired several technical certifications that complement his research expertise. He completed a Data Analysis with R program through Mindluster, enhancing his data analysis skills. Additionally, he has obtained certifications in Data Analysis with Python and Linux from Udemy, further strengthening his computational abilities. Mr. Ali also completed a Content Writing course through the DigiSkills Training Program from Virtual University, Lahore, improving his communication and writing skills for scientific documentation. These certifications underscore his commitment to continuous learning and professional development in bioinformatics and computational biology.

Awards and Achievements

Mr. Syed Luqman Ali has made significant contributions to the scientific community, with multiple publications in high-impact journals, showcasing his research prowess in bioinformatics and computational biology. His work has been recognized by peers and researchers worldwide. Additionally, Mr. Ali serves as a reviewer for several reputed scientific journals, contributing his expertise to the advancement of research. These achievements reflect his dedication to scientific excellence and his active role in shaping future advancements in his field. 📚🖋️🔬

Research Focus

Mr. Syed Luqman Ali’s research spans multiple bioinformatics and computational biology domains, particularly in vaccine and drug design, cancer immunology, and genomics. His work includes multi-epitope vaccine development using immunoinformatics and reverse vaccinology approaches, along with genomic annotation for vaccine target identification. He has contributed significantly to disease diagnostics and drug discovery, especially in areas like tuberculosis, SARS-CoV-2, Leishmania, and autoimmune disorders. His expertise also extends to advanced data analysis, molecular docking, and RNA-seq analysis, employing tools like KEGG, MetaCyc, and HADDOCK. 🧬💻💉

Publication Top Notes

  • Mutational screening of GDAP1 in dysphonia associated with Charcot-Marie-Tooth disease: clinical insights and phenotypic effects
    Cited by: 20
    Year: 2023
  • Vaccinomics-based next-generation multi-epitope chimeric vaccine models prediction against Leishmania tropica – a hierarchical subtractive proteomics and …
    Cited by: 15
    Year: 2023
  • Genomic annotation for vaccine target identification and immunoinformatics-guided multi-epitope-based vaccine design against Songling virus through screening its whole genome …
    Cited by: 12
    Year: 2023
  • Currently trending and futuristic biological modalities in the management of different types of diabetes: A comprehensive review
    Cited by: 9
    Year: 2023
  • Analysis of the capability of IgG antibodies and receptors with their relationships to food tolerance and autoimmune disorders
    Cited by: 6
    Year: 2023
  • Illuminating the Frontier of Drug Discovery: Unleashing the Power of Bioinformatics for Unprecedented Breakthroughs
    Cited by: 4
    Year: 2023
  • Leveraging computer-aided design and artificial intelligence to develop a next-generation multi-epitope tuberculosis vaccine candidate
    Cited by: 1
    Year: 2024
  • Genetic identification and determination of parasites (Babesia, Leptospira and Toxoplasma Gondi) in wild rats
    Cited by: 1
    Year: 2024
  • Placental histology for targeted risk assessment of recurrent spontaneous preterm birth
    Cited by: 1
    Year: 2024
  • Harnessing bioinformatics for the development of a promising multi-epitope vaccine against tuberculosis: The ZL9810L vaccine
    Cited by: 1
    Year: 2024
  • Promising vaccine models against astrovirus MLB2 using integrated vaccinomics and immunoinformatics approaches
    Cited by: 1
    Year: 2024
  • Multi-epitope-based vaccine models prioritization against Astrovirus MLB1 using immunoinformatics and reverse vaccinology approaches
    Cited by: 1
    Year: 2025
  • Exploring advanced genomic and immunoinformatics techniques for identifying drug and vaccine targets against SARS-CoV-2
    Cited by: 1
    Year: 2024
  • A Comprehensive Methodological Review of Major Developments in Bioinformatics Pipelines for Transcriptomic Data Analysis
    Cited by: –
    Year: 2024
Conclusion

Mr. Ali’s solid academic background, innovative research contributions, advanced technical skills, and role as a mentor, he is undoubtedly a strong candidate for the Research for Best Researcher Award. His work in bioinformatics, drug design, vaccine development, and cancer research showcases his dedication to advancing scientific knowledge and making a global impact.